Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Biopsy, Fine-Needle × Clear all

Phase

Phase NA 21 Phase EARLY_PHASE1 3 Phase 1/2 2 Phase 4 1 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 1284 Carboplatin 1198 Cyclophosphamide 1141 Gemcitabine 1044 Bevacizumab 1034 Paclitaxel 1026 Radiotherapy 1012 Docetaxel 943 pembrolizumab 877 Oxaliplatin 788 Capecitabine 770 Fluorouracil 724 Rituximab 631 Doxorubicin 569 Nivolumab 567 Dexamethasone 565 Etoposide 558 Irinotecan 544 Leucovorin 502 Pemetrexed 429 Drug Therapy 408 Cetuximab 405 Cytarabine 401 Trastuzumab 399 Filgrastim 377 Magnetic Resonance Spectroscopy 373 Prednisone 363 Lenalidomide 346 Bortezomib 342 Temozolomide 334

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01196936 2026-01-05

LDTam

University of Alabama at Birmingham

Phase 2 Active not recruiting

84 enrolled 17 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡